To discuss the challenges and opportunities in achieving sustainability in laboratory environments.
Approach:
Sustainability Challenges: Identifies structural challenges in the life sciences industry regarding sustainability, emphasizing the need for high-quality scientific standards.
Generational Perspectives: Highlights the influence of younger scientists on sustainability practices and the gradual shift in perceptions among established researchers.
Key Sustainability Issues: Discusses cold chain storage, single-use plastics, energy consumption, and outdated infrastructure as major sustainability challenges.
Balancing Sustainability and Science: Explores the necessity of integrating sustainability with scientific rigor and the importance of collaboration across teams.
Logistics Impact: Examines the significant carbon footprint of logistics in laboratory settings, particularly concerning cold chain products.
Key Findings:
Sustainability in laboratories is structurally challenging due to strict scientific standards.
Younger scientists are more inclined toward sustainability, influencing practices in academia.
Cold chain storage, single-use plastics, and energy consumption are major sustainability hurdles.
Collaboration is essential for integrating sustainability with scientific performance.
Logistics, especially cold chain transport, significantly contributes to a lab's carbon footprint.
Interpretation:
Limitations:
Many laboratories operate in outdated facilities that hinder sustainability improvements.
Sustainability changes often require organizational strategies beyond individual scientists' control.
Maintaining scientific quality limits the extent to which sustainability practices can be implemented.
Conclusion:
Achieving sustainability in laboratories requires a multifaceted approach that maintains scientific integrity.
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
